RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32
Published January 8, 2020 · Recall initiated: December 13, 2019
Summary
FDA records drug Class II recall D-0632-2020, published January 8, 2020 and initiated December 13, 2019. Recalling firm: Granules India Limited; Status: Ongoing; Reported quantity: 23,090,000 tablets; Lot: 7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What to do
Voluntary: Firm initiated · Letter
Get an email if RANITIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- RANITIDINE
- Manufacturer
- Granules India Limited
- Distributor
- OR, NY, NJ
- Lot
- 7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDARanitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only, Distributed by:January 8, 2020
- FDASilver Bullet, Get Bigger and Harder, Works in Minutes, Lasts for Days, 10 male enhancement capsules inJanuary 8, 2020
- FDAPCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only,January 8, 2020
- FDABimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle,January 8, 2020
- FDAPTS Panels CHOL+HDL+GLU Test Strips, Reference Number 5412, for use on CardioChek PA or CardioChek PlusJanuary 1, 2020
- FDABARD MAX-CORE Disposable Core Biopsy Instrument - Product Usage: The core needle biopsy device is intended forJanuary 1, 2020
Questions about this recall
Was RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32 recalled?
Yes. FDA published recall D-0632-2020 on January 8, 2020. Reported hazard: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: RANITIDINE.